In the present study, α-Hed upregulated p62 in the NSCLC cells time- and dose-dependently (Figure 2A,B), suggesting that α-Hed is probably an autophagy inhibitor. The gene discussed is NKAPD1; the disease is non-small cell lung carcinoma.